These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8901674)
1. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Weir EK; Reeve HL; Huang JM; Michelakis E; Nelson DP; Hampl V; Archer SL Circulation; 1996 Nov; 94(9):2216-20. PubMed ID: 8901674 [TBL] [Abstract][Full Text] [Related]
2. Anorectic drugs and pulmonary hypertension from the bedside to the bench. Michelakis ED; Weir EK Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870 [TBL] [Abstract][Full Text] [Related]
3. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension. Weir EK; Reeve HL; Johnson G; Michelakis ED; Nelson DP; Archer SL Chest; 1998 Sep; 114(3 Suppl):200S-204S. PubMed ID: 9741569 [TBL] [Abstract][Full Text] [Related]
4. Long term effects of the anorectic agent fenfluramine alone and in combination with aminorex on pulmonary and systemic circulation in the pig. Mlczoch J; Weir EK; Reeves JT; Grover RF Basic Res Cardiol; 1979; 74(3):313-20. PubMed ID: 475736 [TBL] [Abstract][Full Text] [Related]
6. Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Hong Z; Smith AJ; Archer SL; Wu XC; Nelson DP; Peterson D; Johnson G; Weir EK Circulation; 2005 Sep; 112(10):1494-9. PubMed ID: 16129789 [TBL] [Abstract][Full Text] [Related]
7. Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential. Reeve HL; Archer SL; Soper M; Weir EK Am J Physiol; 1999 Sep; 277(3):L662-6. PubMed ID: 10484475 [TBL] [Abstract][Full Text] [Related]
8. Aminorex, dexfenfluramine, and primary pulmonary hypertension. Kramer MS; Lane DA J Clin Epidemiol; 1998 Apr; 51(4):361-4. PubMed ID: 9539893 [TBL] [Abstract][Full Text] [Related]
9. [Anorectics and pulmonary hypertension]. Bíbová J; Hampl V Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic dexfenfluramine treatment on pulmonary hemodynamics in dogs. Naeije R; Maggiorini M; Delcroix M; Leeman M; Mélot C Am J Respir Crit Care Med; 1996 Nov; 154(5):1347-50. PubMed ID: 8912746 [TBL] [Abstract][Full Text] [Related]
12. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. Naeije R; Wauthy P; Maggiorini M; Leeman M; Delcroix M Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):692-7. PubMed ID: 7881658 [TBL] [Abstract][Full Text] [Related]
13. The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance. Higenbottam T; Marriott H; Cremona G; Laude E; Bee D Chest; 1999 Oct; 116(4):921-30. PubMed ID: 10531154 [TBL] [Abstract][Full Text] [Related]
14. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Eddahibi S; Raffestin B; Launay JM; Sitbon M; Adnot S Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1111-9. PubMed ID: 9563727 [TBL] [Abstract][Full Text] [Related]
15. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791 [TBL] [Abstract][Full Text] [Related]
16. Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine. Hong Z; Olschewski A; Reeve HL; Nelson DP; Hong F; Weir EK Am J Physiol Lung Cell Mol Physiol; 2004 Mar; 286(3):L531-8. PubMed ID: 14607779 [TBL] [Abstract][Full Text] [Related]
19. Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology. Reeve HL; Nelson DP; Archer SL; Weir EK Am J Physiol; 1999 Feb; 276(2):L213-9. PubMed ID: 9950882 [TBL] [Abstract][Full Text] [Related]